147 related articles for article (PubMed ID: 38189969)
1. The significance of the presence of extranodal extension in the metastatic node of differentiated thyroid cancer: a proposal for modification in the American Thyroid Association (ATA) risk stratification.
Chidambaranathan N; Thiagarajan S; Gurukeerthi B; Sathe P; Samel P; Ramalingam N; Chaukar D
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1923-1931. PubMed ID: 38189969
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Metastatic Lymph Nodes on Risk Stratification in Differentiated Thyroid Cancer: Have We Reached a Higher Level of Understanding?
Urken ML; Haser GC; Likhterov I; Wenig BM
Thyroid; 2016 Apr; 26(4):481-8. PubMed ID: 26892765
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment and prognosis values of extranodal extension to recurrent laryngeal nerve in papillary thyroid carcinoma.
Abuduwaili M; Aili A; Xia B; Chen Z; Wu Z; Xing Z; Fei Y; Su A
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2341-2349. PubMed ID: 36528844
[TBL] [Abstract][Full Text] [Related]
5. Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Song E; Ahn J; Song DE; Kim WW; Jeon MJ; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
Clin Endocrinol (Oxf); 2020 Apr; 92(4):358-365. PubMed ID: 31630423
[TBL] [Abstract][Full Text] [Related]
6. Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.
Kim HI; Hyeon J; Park SY; Ahn HS; Kim K; Han JM; Bae JC; Shin JH; Kim JS; Kim SW; Chung JH; Kim TH; Oh YL
Thyroid; 2019 Jul; 29(7):963-970. PubMed ID: 31025609
[No Abstract] [Full Text] [Related]
7. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
9. Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.
Hei H; Gong W; Zheng C; Zhou B; Qin J
Endocrine; 2022 Jun; 77(1):73-79. PubMed ID: 35389141
[TBL] [Abstract][Full Text] [Related]
10. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.
Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML
Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810
[TBL] [Abstract][Full Text] [Related]
11. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
[TBL] [Abstract][Full Text] [Related]
12. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
[TBL] [Abstract][Full Text] [Related]
13. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
14. Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Feb; 24(2):460-468. PubMed ID: 27654105
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
[TBL] [Abstract][Full Text] [Related]
16. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer.
Lee J; Kim CH; Min IK; Jeong S; Kim H; Choi MJ; Kwon HJ; Jung SG; Jo YS
Eur J Endocrinol; 2020 Jul; 183(1):83-93. PubMed ID: 32487777
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X; Yang X; Yang W; Shui R
Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
[TBL] [Abstract][Full Text] [Related]
18. Male patients with papillary thyroid cancer have a higher risk of extranodal extension.
Hei H; Zhou B; Gong W; Zheng C; Qin J
Int J Clin Oncol; 2022 Apr; 27(4):648-654. PubMed ID: 35000041
[TBL] [Abstract][Full Text] [Related]
19. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
20. Extranodal Extension Is an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
Zhou TH; Lin B; Wu F; Lu KN; Mao LL; Zhao LQ; Jiang KC; Zhang Y; Zheng WJ; Luo DC
Front Endocrinol (Lausanne); 2021; 12():759049. PubMed ID: 34803921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
